s2
    We seek to elucidate the origin, the evolution
    and the heterogeneity of colorectal cancer
    s1
    We develop state-of-the-art tools and techniques
    to study colorectal cancer heterogeneity and stem cell dynamics
    s3
    We are a highly multidisciplinary group, we approach
    scientific questions from many different perspectives

    Welcome to the Louis Vermeulen laboratory website

    Vermeulen Lab seeks to elucidate the origin, the evolution and the heterogeneity of colorectal cancer. We have set up and developed a collection of state-of-the-art tools and techniques to study colorectal cancer heterogeneity and stem cell dynamics. One key characteristic of our group is the highly multidisciplinary composition, which allows us to approach scientific questions from many different perspectives.

    Recent news

    New paper in Cell Stem Cell!

    https://pubmed.ncbi.nlm.nih.gov/34358441/
    Read More

    New paper in Cell Reports

    https://pubmed.ncbi.nlm.nih.gov/34686335/
    Read More

    Sanne van Neerven wins Birnstiel award for young scientists

    https://www.amsterdamumc.org/en/research/institutes/cancer-center-amsterdam/news/sanne-van-neerven-wins-prestigious-international-young-scientists-award.htm
    Read More

    Recent publications

    Continuous clonal labeling reveals uniform progenitor potential in the adult exocrine pancreas.

    Cell Stem Cell, 2021 28(11), 2009-2019.e4
    Lodestijn SC, van den Bosch T, Nijman LE, Moreno LF, Schlingemann S, Sheraton VM, van Neerven SM, Koning JJ, Vieira Braga FA, Paauw NJ, Lecca MC, Lenos KJ, Morrissey E, Miedema DM, Winton DJ, Bijlsma MF, Vermeulen L
    The tissue dynamics that govern maintenance and regeneration of the pancreas remain largely unknown. In particular, the presence and nature of a cellular hierarchy remains a topic of debate. Previous lineage tracing strategies in the pancreas relied on specific marker…
    Read More

    Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer.

    Cell Rep, 2021 37(3), 109852
    Lodestijn SC, Miedema DM, Lenos KJ, Nijman LE, Belt SC, El Makrini K, Lecca MC, Waasdorp C, van den Bosch T, Bijlsma MF, Vermeulen L
    Effective treatments for pancreatic ductal adenocarcinoma (PDAC) are lacking, and targeted agents have demonstrated limited efficacy. It has been speculated that a rare population of cancer stem cells (CSCs) drives growth, therapy resistance, and rapid metastatic progression in PDAC. These…
    Read More

    The recurring features of molecular subtypes in distinct gastrointestinal malignancies-A systematic review.

    Crit Rev Oncol Hematol, 2021 164103428
    Adam RS, Blomberg I, Ten Hoorn S, Bijlsma MF, Vermeulen L
    In colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC) and gastric cancer (GC) multiple studies of inter-tumor heterogeneity have identified molecular subtypes, which correlate with clinical features. Our aim was to investigate the attributes of molecular subtypes across three different gastrointestinal…
    Read More